Hot Features
Premium
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 970,910 |
|
|||||
| News | (1) | ||||||
| Day High | 0.4389 | Low High |
|||||
| Day Low | 0.38 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Clene Inc | CLNN | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.0166 | -3.84% | 0.4152 | 18:23:58 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.4168 | 0.38 | 0.4389 | 0.437 | 0.4318 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,492 | 970,910 | US$ 0.4155892 | US$ 403,500 | - | 0.25 - 1.09 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:23:57 | formt | 130 | US$ 0.4152 | USD |
Clene Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 56.51M | 128.43M | - | 654k | -49.5M | -0.39 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Clene News
| Date | Time | Source | News Article |
|---|---|---|---|
| 5/01/2024 | 07:30 | GlobeNewswire Inc. | IBN Announces From Lab to Launch Podcast Featuring Clene.. |
| 3/19/2024 | 07:30 | GlobeNewswire Inc. | IBN Announces First in Human Podcast Featuring Clene Inc... |
| 2/29/2024 | 07:05 | Edgar (US Regulatory) | Form 8-K - Current report |
| 2/22/2024 | 07:04 | Edgar (US Regulatory) | Form 8-K - Current report |
| 2/14/2024 | 16:21 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial.. |
| 2/13/2024 | 16:05 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial.. |
| 1/31/2024 | 15:16 | Edgar (US Regulatory) | Form 8-K - Current report |
| 1/08/2024 | 06:07 | Edgar (US Regulatory) | Form 8-K - Current report |
| 12/21/2023 | 06:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 11/29/2023 | 15:10 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 11/29/2023 | 15:09 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 11/29/2023 | 15:09 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CLNN Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.3384 | 0.439 | 0.325 | 0.4064736 | 664,178 | 0.0768 | 22.70% |
| 1 Month | 0.40 | 0.46 | 0.304 | 0.344306 | 1,497,824 | 0.0152 | 3.80% |
| 3 Months | 0.43 | 0.5323 | 0.304 | 0.3838779 | 966,463 | -0.0148 | -3.44% |
| 6 Months | 0.3912 | 0.60 | 0.25 | 0.3799686 | 925,647 | 0.024 | 6.13% |
| 1 Year | 0.97 | 1.09 | 0.25 | 0.4949047 | 687,809 | -0.5548 | -57.20% |
| 3 Years | 9.29 | 17.82 | 0.25 | 2.53 | 546,833 | -8.87 | -95.53% |
| 5 Years | 9.55 | 17.82 | 0.25 | 2.94 | 512,337 | -9.13 | -95.65% |
Clene Description
| Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. Its reportable segments: (1) the development and commercialization of novel clean-surfaced nanotechnology therapeutics (Drugs, and (2) the development and commercialization of dietary supplements (Supplements). |
